Mushrooms (Culinary) for Cancer Risk Reduction

Research suggests that culinary mushrooms may be associated with a reduced risk of cancer, with the proposed mechanisms involving bioactive compounds such as phenolics, flavonoids, and other nutritional constituents that have demonstrated antioxidant and anticancer activity in studies. The available evidence on this topic, however, is currently limited to a single 2022 narrative review that synthesizes existing literature rather than presenting original clinical trial data, meaning the findings should be interpreted with caution. Studies indicate that mushrooms contain a range of biologically active molecules that show promise in laboratory and observational contexts, but the review itself acknowledges that more targeted research is needed before stronger conclusions can be drawn. Readers should be aware that a narrative review of this kind reflects the authors' synthesis of prior work and does not carry the same evidentiary weight as randomized controlled trials or systematic meta-analyses.